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The generation of mature red blood cells is initiated from the commitment of hematopoietic stem cells to erythroid progenitors, which is followed by their differentiation to a series of morphologically recognizable erythroblasts 1 . At the end of terminal erythropoiesis, the highly condensed nucleus migrates to one side of the cytoplasm of orthochromatic erythroblast, which is followed by the unique enucleation process producing reticulocytes and mature red blood cells [2] [3] [4] . Our previous study demonstrated that mDia2, which belongs to the mDia formin protein family 5 , is a downstream effector protein of Rac GTPases regulating late-stage terminal erythropoiesis, especially enucleation 6 . Here we generated conditional mDia2 knockout mouse models to reveal the roles of mDia2 in adult erythropoiesis. The conditional mDia2 knockout mouse models utilized an mDia2 targeting allele with exons 10 and 11 floxed. The LacZ and neomycin cassettes were flanked by FRT to be removed by FLP recombinase (Online Supplementary Figure S1A ). We first crossed mDia2 fl/+ mice with E2A-Cre transgenic mice to generate whole body mDia2 knockout mice. The depletion of mDia2 mRNA and protein were confirmed by real time-PCR and western blot assays (Online Supplementary Figure S1B and C, respectively). Same as previously reported 7 , mDia2 fl/fl E2A-Cre mice were never generated alive (Online Supplementary Figure S1D ). We found that the mDia2 knockout embryos die in uterus at approximately embryonic day 12.5 (E12.5) (Online Supplementary Figure S1E ). This demonstrates that mDia2 is essential for embryonic development, which compromises the study of the roles of mDia2 in vivo in adult.
To determine the specific roles of mDia2 in adult erythropoiesis, we crossed mDia2 fl/fl mice with
Mx-Cre transgenic mice in which Cre recombinase is under the control of the interferon 4 inducible promoter of Mx-1 gene 8 . Relative hematopoietic cell specific mDia2 inducible knockout mice were generated by polyinosinic:polycytidylic acid (poly-IC) peritoneal injection when the mDia2 fl/fl Mx-Cre mice were 6 weeks old. mDia2 fl/fl and mDia2 +/+ Mx-Cre mice with the same poly-IC injection were used as controls. Ten weeks after poly-IC injection, the depletion of mDia2 in bone marrow cells was confirmed (Online Supplementary Figure S2A ). Mx-Cre mice exhibited significant anemia demonstrated by the decreased hemoglobin, total red blood cell count, and hematocrit ( Figure 1A and data not shown). Red cell distribution width (RDW) is dramatically increased, reflecting variation of the size of red blood cells ( Figure   1A ). These changes in red blood cell indices were specific since total white blood cell count remained unchanged ( Figure 1A ). These results indicate that mDia2 plays a unique role in the erythroid lineage.
We next examined the morphology of the hematopoietic cells from mDia2 fl/fl Mx-Cre mice. In peripheral blood, these mice exhibited anemia with anisopoikilocytosis including macrocytes, microcytes, occasional spherocytes, and hypochromic cells, which is consistent with the increased RDW. Polychromasia was relatively increased with abnormally large reticulocytes ( Figure 1B ). The morphology of granulocytes and lymphocytes from these mice were similar to those from the controls (data not shown). These results indicate that mDia2 could be functionally important to maintain the membrane and cytoskeletal integrity of the mature red blood cells.
Additionally, we generated mDia2 Mx-Cre mice (Online Supplementary Figure S2B ).
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To determine the etiology of these abnormalities, we analyzed the bone marrow and spleen cells from mDia2
fl/fl
Mx-Cre and control mice 10 weeks after poly-IC injection. Terminal differentiation of bone marrow CD45 negative erythroid cells was examined using flow cytometric analysis of CD44 surface expression together with forward scatter 9 . In this assay, the CD45 negative erythroid cells were further gated based on their surface levels of CD44, which gradually decreases during cell maturation 10 . As previously reported, we divided the cells into Mx-Cre mice ( Figure 1C ), we found that most of the binucleated erythroblasts were in stage IV orthochromatic phase of differentiation in bone marrow ( Figure 2H ). This is consistent with the morphologic findings ( Figure 2A ).
To further understand the mechanism of mDia2 in erythropoiesis, we used a well established mouse erythroblasts in vitro differentiation system [11] [12] [13] . Compared to the controls, the lineage We next attempted to rescue anemia in mDia2 deficient mice. Previous reports showed that macrophages contribute to the pathogenesis of ineffective erythropoiesis in beta-thalassemia 14, 15 .
Depletion of macrophages by a single dose of clodronate significantly improves anemia in betathalassemia mouse model 14 . We therefore treated these mice similarly with a single dose of clodronate, followed by complete blood count and blood smear examination. This treatment led 8 to a significant improvement of anemia as indicated by increased red blood cell counts, hemoglobin levels and hematocrit ( Figure 3A and B). We confirmed the depletion of macrophages in bone marrow (Online Supplementary Figure S4A and B). Bone marrow examination also showed that clodronate reduced the percentage of early stage erythroblasts whereas reticulocytes and red blood cells (populations V and VI, respectively) were significantly increased ( Figure 3C ). Although spleen already showed compensation in mDia2 conditional knockout mice (Online Supplementary Figure S2G ), clodronate treatment further reduced the early stage ineffective erythroblasts ( Figure 3D ). Consistently, the improved erythropoiesis in bone marrow and spleen led to a normalized spleen weight ( Figure 3E) . These results further demonstrate the therapeutic effects of macrophage depletion in the treatment of ineffective erythropoiesis.
In summary, our study reveals the key roles of mDia2 in adult terminal erythropoiesis. Loss of mDia2 affects terminal erythropoiesis particularly in the orthochromatic stage by compromising cytokinesis and enucleation of the condensed nuclei. This leads to the inhibition of differentiation of the early-stage erythroblasts. These pathologic features closely mimic certain inherited diseases in human such as congenital dyserythropoietic anemia, which indicates that mDia2 may play a role in its pathogenesis. Additionally, the mDia2 conditional and tissue specific knockout mouse models also provide tools to study the functions of mDia2 in different organ systems. Populations I-VI were defined as proerythroblasts, basophilic erythroblasts, polychromatic erythroblasts, orthochromatic erythroblasts, reticulocytes, and red blood cells, respectively 9 .
Statistical analysis of (C) and (E) were shown in (D) and (F) respectively. N=3 in each group. * P<0.05; ** P<0.005; *** P<0.0005. Polyclonal anti-mouse mDia2 antibody was generated by immunizing rabbits with mDia2
proteins according to standard procedure.
RNA extraction and quantitative RT-PCR
The total RNA was extracted using Trizol reagent according to the manufacturer's protocol (life technologies). 1µg total RNA was used for the reverse transcription by qScript cDNA supermix 
Mice genotyping
The genotype of Diap3 floxed alleles was assayed by genomic PCR using the follow primers:
forward: expression and forward scatter as in Figure 1C and 1E, were shown in (E) for bone marrow and in (F) for spleen from mDia2 fl/fl Vav-Cre and control mice. Quantitative analysis of spleen weight from these mice was shown in (G). All the experiments were repeated at least three times. 
